Clinical Trials Directory

Trials / Sponsors / Cascade Pharmaceuticals, Inc

Cascade Pharmaceuticals, Inc

Academic / Other · 13 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of CS060380 Tablets in Patients With MASH and Obesity
Metabolic Dysfunction-associated Steatohepatitis (MASH), Obesity
Phase 22026-04-02
Not Yet RecruitingDrug Interaction and Food Effect Study of CS0159
Healthy Volunteers
Phase 12026-03-01
RecruitingA Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Primary Biliary Cholangitis
Phase 32025-12-01
RecruitingTrial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)
NASH
Phase 22025-09-30
Active Not RecruitingStudy to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects
MASH
Phase 12025-04-22
CompletedA Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury
Primary Biliary Cholangitis
Phase 12025-03-13
CompletedStudy to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects
MASH
Phase 12024-09-03
CompletedStudy of [14C]CS0159 in China Healthy Subjects
Primary Biliary Cholangitis
Phase 12023-10-23
Active Not RecruitingCS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
Primary Biliary Cholangitis (PBC)
Phase 22023-08-07
Active Not RecruitingCS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
Primary Sclerosing Cholangitis
Phase 22023-08-07
CompletedA Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH
Nonalcoholic Steatohepatitis (NASH)
Phase 22023-02-10
CompletedStudy to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese Healthy Subjects
Primary Biliary Cholangitis
Phase 12022-12-19
CompletedStudy in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0
Primary Sclerosing Cholangitis (PSC)
Phase 12021-10-26